Truist raised the firm’s price target on Crispr Therapeutics (CRSP) to $120 from $100 and keeps a Buy rating on the shares. The company’s Q4 ...

Truist Financial analyst Terry Tillman maintained a Buy rating on nCino (NCNO – Research Report) today. The company’s shares closed yesterday ...

Truist Securities adjusted its outlook on Confluent Inc (NASDAQ:CFLT), increasing the price target to $40 from the previous ...

Truist Financial Corporation ( NYSE: TFC) UBS Financial Services Conference February 11, 2025 1:00 PM ET Buddy, as I say, no rest for the weary. But obviously my energy levels are back up, because we ...

Winnebago Industries (NYSE:WGO – Get Free Report) had its target price boosted by equities research analysts at Truist ...

Patrick Industries (NASDAQ:PATK – Get Free Report) had its target price raised by investment analysts at Truist Financial ...

Discover Truist’s checking account features, fees, and benefits in our comprehensive review. Learn how to maximize perks and ...

Money from the program will be used by nonprofit groups to help rebuild small businesses, housing and infrastructure in 39 counties.

We recently compiled a list of the 10 Best Local Bank Stocks to Buy. In this article, we are going to take a look at where ...

On Tuesday, March 25, the South Carolina Gamecocks will take on the UNC Tar Heels for the ninth straight time at the home of ...

Pacira BioSciences (PCRX) stock was upgraded by Truist based on a potential settlement to its patent dispute with eVenus ...

Truist Securities revised its price target for Lyft (NASDAQ:LYFT) shares, reducing it from $20.00 to $17.00, while maintaining a Hold rating. Currently trading at $14.39, Lyft has shown significant ...